Abstract
Nephrotoxicity, the most important toxicity in high-dose methotrexate (MTX) therapy, is partly caused by the formation of crystal deposits in the kidney due to poor water solubility of MTX and its metabolites 7-hydroxy methotrexate (7-OH MTX), deoxyaminopteroic acid (DAMPA) and 7-hydroxy deoxyaminopteroic acid (7-OH DAMPA). Plasma MTX level-guided urine alkalinization, leucovorin rescue and glucarpidase detoxification are common strategies to overcome MTX-related nephrotoxicity. However, overestimation is a problem for MTX analysis by immunoassays due to the cross-reactivity of MTX metabolites (7-OH MTX and DAMPA). An UHPLC-MS/MS method for the simultaneous determination of MTX, 7-OH MTX, DAMPA and 7-OH DAMPA in human urine was developed, validated and applied in clinical practice. Samples were treated by one-step protein precipitation and analyzed within 3 min. The calibration range was 0.02 to 4 µmol/L for MTX and DAMPA, and 0.1 to 20 µmol/L for 7-OH MTX and 7-OH DAMPA. For all analytes, the intra-day and inter-day bias and imprecision were–8.0 to 7.6 and <9.0%, the internal standard normalized recovery and matrix factor were 92.34 to 109.49 and <20.68%. The plasma MTX and 7-OH MTX levels increased with the urine drug levels, age, serum creatinine and alanine transaminase, but urine could not replace blood for MTX monitoring due to their poor correlation (R2, 0.16 to 0.51). Dose-normalized urine and plasma MTX and 7-OH MTX levels were similar between different patient groups (urine pH <7 or ≥7). Due to the large inter-individual variance of the analytes levels in both plasma and urine, these findings should be treated with caution.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Hospira, Label for Methotrexate Injection, http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/011719s117lbl.pdf2011.
R.C. Schofield, L.V. Ramanathan, K. Murata, M. Grace, M. Fleisher, M.S. Pessin, D.C. Carlow, J. Chromatogr. B, 2015, 1002, 169.
M. Uchiyama, T. Matsumoto, T. Matsumoto, S. Jimi, Y. Takamatsu, K. Tamura, S. Hara, Biomed. Chromatogr., 2012, 26, 76.
F. Berga, P. Luna, C. Martorell, J. Rey, I. Gomila, S. Gimenez, A. Costa-Bauza, M.A. Elorza, I. Sanchez, F. Grases, B. Barcelo, Clin. Chim. Acta, 2018, 487, 1.
E. Klapkova, J. Kukacka, K. Kotaska, I. Suchanska, R. Urinovska, R. Prusa, Clin. Lab., 2011, 57, 599.
S.A. Jacobs, R.G. Stoller, B.A. Chabner, D.G. Johns, J. Clin. Invest., 1976, 57, 534.
L.B. Ramsey, F.M. Balis, M.M. O'Brien, K. Schmiegelow, J.L. Pauley, A. Bleyer, B.C. Widemann, D. Askenazi, S. Bergeron, A. Shirali, S. Schwartz, A.A. Vinks, J. Heldrup, Oncologist, 2018, 23, 52.
T.E. Sand and S. Jacobsen, Eur. J. Clin. Pharmacol., 1981, 19, 453.
O. Mir, S. Ropert, A. Babinet, J. Alexandre, F. Larousserie, J.P. Durand, E. Enkaoua, P. Anract, F. Goldwasser, Cancer Chemother. Pharmacol., 2010, 66, 1059.
S.A. Drost, J.R. Wentzell, P. Giguere, D.L. McLurg, M. Sabloff, S. Kanji, T.T. Nguyen, Pharmacotherapy, 2017, 37, 684.
S. Mei, X. Li, X. Jiang, K. Yu, S. Lin, Z. Zhao, J. Pharm. Sci., 2018, 107, 1454.
J.B. Oudart, B. Marquet, C. Feliu, C. Gozalo, Z. Djerada, H. Millart, Ann. Biol. Clin., 2016, 74, 333.
S. Mei, L. Zhu, X. Li, J. Wang, X. Jiang, H. Chen, J. Huo, L. Yang, S. Lin, Z. Zhao, Anal. Sci., 2017, 33, 665.
R.C. Schofield, L.V. Ramanathan, K. Murata, M. Fleisher, M.S. Pessin, D.C. Carlow, Methods Mol. Biol., 2016, 1383, 213.
M.S. Roberts, N.S. Selvo, J.K. Roberts, V.M. Daryani, T.S. Owens, K.E. Harstead, A. Gajjar, C.F. Stewart, J. Liq. Chromatogr. Relat. Technol., 2016, 39, 745.
M.A. Al-Ghobashy, S.A. Hassan, D.H. Abdelaziz, N.M. Elhosseiny, N.A. Sabry, A.S. Attia, M.H. El-Sayed, J. Chromatogr. B, 2016, 1038, 88.
D. Wu, Y. Wang, Y. Sun, N. Ouyang, J. Qian, Biomed. Chromatogr., 2015, 29, 1197.
C.C. Christianson, C.J. Johnson, S.R. Needham, Bioanalysis, 2013, 5, 1387.
R. Bouquié, G. Deslandes, B.N. Bernâldez, C. Renaud, E. Dailly, P. Jolliet, Anal. Methods, 2013, 6, 178.
E. den Boer, S.G. Heil, B.D. Van Zelst, R.J. Meesters, B.C. Koch, M.L. Te Winkel, M.M. Van den Heuvel-Eibrink, T.M. Luider, R. de Jonge, Ther. Drug Monit., 2012, 34, 432.
H.L. Cheng, S.S. Chiou, Y.M. Liao, C.Y. Lu, Y.L. Chen, S.M. Wu, Anal. Bioanal. Chem., 2010, 398, 2183.
S. Mei, X. Shi, Y. Du, Y. Cui, C. Zeng, X. Ren, K. Yu, Z. Zhao, S. Lin, J. Pharm. Biomed. Anal., 2018, 158, 300.
A. Barbieri, L. Sabatini, P. Indiveri, R. Bonfiglioli, V. Lodi, F.S. Violante, Rapid Commun. Mass Spectrom., 2006, 20, 1889.
J. Bluett, I. Riba-Garcia, K. Hollywood, S.M. Verstappen, A. Barton, R.D. Unwin, Analyst, 2015, 140, 1981.
G. Fabrizi, M. Fioretti, L. Mainero Rocca, Biomed. Chromatogr., 2016, 30, 1297.
P. Koufopantelis, S. Georgakakou, M. Kazanis, C. Giaginis, A. Margeli, S. Papargiri, I. Panderi, J. Chromatogr. B, 2009, 877, 3850.
EMEA, Committee for Medicinal Products for Human Use, Guideline on Bioanalytical Method Validation, EMEA/ CHMP/EWP/192217/2009 Rev. 1 Corr. 2** (21 July 2011), http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500109686.pdf2011.
FDA, Guidance for Industry: Bioanalytical Method Validation, https://www.fda.gov/media/70858/download2018.
H. Jiang, H. Cao, Y. Zhang, D.M. Fast, J. Chromatogr. B, 2012, 891-892, 71.
N.R. Srinivas, Biomed. Chromatogr., 2011, 25, 740.
L. Hu, J.E. Agbokponto, L. Ding, B. Liu, F. Shi, C. Gong, Biomed. Chromatogr., 2015, 29, 53.
B. Winograd, R.J. Lippens, M.J. Oosterbaan, M.J. Dirks, T.B. Vree, E. Van der Kleijn, Eur. J. Clin. Pharmacol., 1986, 30, 231.
P. Bore, A. Iliadis, J. Catalin, S. Just, J.P. Cano, Cancer Drug Deliv., 1987, 4, 177.
T.S. Mikkelsen, C.F. Thorn, J.J. Yang, C.M. Ulrich, D. French, G. Zaza, H.M. Dunnenberger, S. Marsh, H.L. McLeod, K. Giacomini, M.L. Becker, R. Gaedigk, J.S. Leeder, L. Kager, M.V. Relling, W. Evans, T.E. Klein, R.B. Altman, Pharmacogenet. Genomics, 2011, 21, 679.
A.K. Fotoohi and F. Albertioni, Leuk. Lymphoma, 2008, 49, 410.
D. French, W. Yang, C. Cheng, S.C. Raimondi, C.G. Mullighan, J.R. Downing, W.E. Evans, C.H. Pui, M.V. Relling, Blood, 2009, 113, 4512.
S. Inoue, M. Hashiguchi, S. Kawai, M. Mochizuki, Yakugaku Zasshi, 2009, 129, 1001.
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Mei, S., Cui, Y., Zhang, D. et al. Simultaneous Determination of Urine Methotrexate, 7-Hydroxy Methotrexate, Deoxyaminopteroic Acid, and 7-Hydroxy Deoxyaminopteroic Acid by UHPLC-MS/MS in Patients Receiving High-dose Methotrexate Therapy. ANAL. SCI. 36, 1479–1483 (2020). https://doi.org/10.2116/analsci.19P481
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2116/analsci.19P481